Author:
Jeon Sojeong,Kim Moon-Moo
Reference33 articles.
1. Wu, S.-S., Li, Q.-C., Yin, C.-Q., et al., Advances in CRISPR/Cas-based gene therapy in human genetic diseases, Theranostics, 2020, vol. 10, p. 4374.
2. Korotkova, A.M., Gerasimova, S.V., Shumny, V.K., and Khlestkina, E., Crop genes modified using the CRISPR/Cas system, Russ. J. Genet.,
Appl. Res., 2017, vol. 7, no. 12, pp. 822—832. https://doi.org/10.1134/S2079059717050124
3. Knott, G.J. and Doudna, J.A., CRISPR-Cas guides the future of genetic engineering, Science, 2018, vol. 361, pp. 866—869.
4. Zhang, F., Development of CRISPR-Cas systems for genome editing and beyond, Q. Rev. Biophys., 2019, vol. 52.
5. Smirnov, A., Yunusova, A., Lukyanchikova, V., and Battulin, N., CRISPR/Cas9, a universal tool for genomic engineering, Russ. J. Genet.,
Appl. Res., 2017, vol. 7, no. 4, pp. 440—458.